头孢噻肟结合中成药对婴幼儿肺炎C-反应蛋白的影响

目的:探讨头孢噻肟结合中成药对婴幼儿肺炎患儿血C-反应蛋白(CRP)水平的影响。方法:对未能住院的42例婴幼儿肺炎采用头孢噻肟结合中成药治疗,并对其治疗前及治疗7d后的血CRP水平、临床症状和体征等进行评估。结果:总有效率为81.0%;血CRP水平从治疗前的(45.27±15.70)mg.L-1降至(10.38±7.26)mg.L-1,前后比较有统计学差异(P<0.01)。结论:头孢噻肟结合中成药对婴幼儿肺炎患儿的血CRP有较好的干预效果,该方法治疗婴幼儿肺炎是可取的、有效的、安全的。

The Intervention of Cefotaxime on C-reaction Protein in Infants with Pneumonia

Objective： To explore the intervention of Cefotaxime on C-reaction protein （CRP）in infants with pneumonia,Method： Forty two outpatiengt infants with pneumonia were cured with Cefotaximec. The levels of serum CRP, clinical symptoms and physical signs were evaluated before therapy and 7days after therapy. Result： The effective rate was 81.0%. The mean level of serum CRP before therapy was （45.27± 15.70）mg·L^-1,and it decreased to （10.38±7.26）mg·L^-1 7days after therapy. There was statistical differenece（P 〈0.01）. Conclusion：Cefotaxime has good intervention effects on serumn CRP in infants with pneumonia,lt is acceptable,effective and safe to infants with pneumonia.